Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
AEMD Aethlon Medical Inc
- Stocks
- Healthcare
- NASDAQ: AEMD
Price (delayed)
$0.4048
Market cap
$5.85M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.58
Enterprise value
$1.63M
Aethlon is focused on addressing unmet needs in global health. The Aethlon Hemopurifier is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. In cancer, the Hemopurifier
Highlights
Aethlon Medical's EPS has surged by 68% YoY and by 44% QoQ
The net income has increased by 22% year-on-year and by 15% since the previous quarter
Aethlon Medical's gross profit has shrunk by 100% YoY
AEMD's revenue has plunged by 100% YoY
Key stats
What are the main financial stats of AEMD
Market
Valuations
Earnings
Shares outstanding
14.46M
Market cap
$5.85M
Enterprise value
$1.63M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.3
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$9.82M
Net income
-$9.56M
EBIT
-$9.56M
EBITDA
-$9.22M
Free cash flow
-$8.55M
Per share
Balance sheet
Liquidity
EPS
-$1.58
EPS diluted
-$1.58
Free cash flow per share
-$0.61
Book value per share
$0.31
Revenue per share
$0
TBVPS
$0.47
Total assets
$6.53M
Total liabilities
$2.19M
Debt
$724,848
Equity
$4.33M
Working capital
$3.19M
Debt to equity
0.17
Current ratio
2.8
Quick ratio
2.79
Net debt/EBITDA
0.46
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-109.1%
Return on equity
-154%
Return on invested capital
-1,056.8%
Return on capital employed
-201.2%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AEMD stock price
How has the Aethlon Medical stock price performed over time
Intraday
-2.27%
1 week
8.03%
1 month
11.52%
1 year
-52.38%
YTD
-52.93%
QTD
13.07%
Financial performance
How have Aethlon Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$9.82M
Net income
-$9.56M
Gross margin
N/A
Net margin
N/A
Aethlon Medical's gross profit has shrunk by 100% YoY
AEMD's revenue has plunged by 100% YoY
The company's operating income rose by 22% YoY and by 15% QoQ
The net income has increased by 22% year-on-year and by 15% since the previous quarter
Price vs fundamentals
How does AEMD's price correlate with its fundamentals
Growth
What is Aethlon Medical's growth rate over time
Valuation
What is Aethlon Medical stock price valuation
P/E
N/A
P/B
1.3
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Aethlon Medical's EPS has surged by 68% YoY and by 44% QoQ
The company's equity fell by 43% YoY and by 28% QoQ
The P/B is 7% below the 5-year quarterly average of 1.4 and 7% below the last 4 quarters average of 1.4
AEMD's revenue has plunged by 100% YoY
Efficiency
How efficient is Aethlon Medical business performance
Aethlon Medical's ROIC has decreased by 45% YoY but it has increased by 4.9% from the previous quarter
The ROE has contracted by 45% YoY but it has grown by 4% from the previous quarter
The ROA has contracted by 26% YoY but it has grown by 6% from the previous quarter
Dividends
What is AEMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AEMD.
Financial health
How did Aethlon Medical financials performed over time
The company's total assets is 198% higher than its total liabilities
The company's total assets fell by 37% YoY and by 26% QoQ
Aethlon Medical's current ratio has decreased by 29% YoY and by 8% QoQ
The company's debt is 83% lower than its equity
The debt to equity has surged by 70% year-on-year and by 31% since the previous quarter
The company's equity fell by 43% YoY and by 28% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.